SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

KOGURE, Gislaine Satyko et al. Análise de força muscular e composição corporal de mulheres com Síndrome dos Ovários Policísticos. Rev. Bras. Ginecol. Obstet. [online]. 2012, vol.34, n.7, pp. 316-322. ISSN 0100-7203.  http://dx.doi.org/10.1590/S0100-72032012000700005.

    1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544-51. [ Links ]

    2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. [ Links ]

    3. Tomlinson J, Millward A, Stenhouse E, Pinkney J. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced? Diabet Med. 2010;27(5):498-515. [ Links ]

    4. Santana LF, Ferriani RA, Sá MFS, Reis RM. Treatment of infertility in women with polycystic ovary syndrome: [review]. Rev Bras Ginecol Obstet. 2008;30(4):201-9. [ Links ]

    5. Marshall JC. Obesity in adolescent girls: is excess androgen the real bad actor? J Clin Endocrinol Metab. 2006;91(2):393-5. [ Links ]

    6. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9. [ Links ]

    7. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril. 2002;77 Suppl 4:S34-41. [ Links ]

    8. Rooyackers OE, Nair KS. Hormonal regulation of human muscle protein metabolism. Annu Rev Nutr. 1997;17:457-85. [ Links ]

    9. Gunther CM, Burger A, Rickert M, Crispin A, Schulz CU. Grip strength in healthy _caucasian adults: reference values. J Hand Surg Am. 2008;33(4):558-65. [ Links ]

    10. De Nicola F, Pepe I, Agrusa A, Cusumano G, Bucchieri S, Scozzari F, et al. Body composition of individuals with polycystic ovary syndrome. Acta Med Mediterr. 2009;25:11-7. [ Links ]

    11. Thomas S, Reading J, Shephard RJ. Revision of the physical activity readiness questionnaire (PAR-Q). Can J Sport Sci. 1992;17(4):338-45. [ Links ]

    12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. [ Links ]

    13. Cascella T, Palomba S, Tauchmanov L, Manguso F, Di Biase S, Labela D, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2006;91(11):4395-400. [ Links ]

    14. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract. 2006;72(2):219-20. [ Links ]

    15. Griffin IJ, Cole TJ, Duncan KA, Hollman AS, Donaldson MD. Pelvic ultrasound measurements in normal girls. Acta Paediatr. 1995;84(5):536-43. [ Links ]

    16. Genton L, Hans D, Kyle UG, Pichard C. Dual-energy X-ray absorptiometry and body composition: differences between devices and comparison with reference methods. Nutrition. 2002;18(1):66-70. [ Links ]

    17. Eston R, Reilly T, editors. Kinanthropometry and exercise physiology laboratory manual: tests, procedures and data. Vol. 1, Anthropometry. 3rd ed. Oxon: Routledge; 2009. [ Links ]

    18. Raso V, Matsudo SMM, Matsudo VKR. A experiência de mulheres idosas em programas de exercícios com pesos não determina a performance no teste 1-RM nem a resposta da percepção subjetiva de esforço. Rev Bras Ciênc Esporte. 2002;23(3):81-92. [ Links ]

    19. Matuszak ME, Fry AC, Weiss LW, Ireland TR, McKnight MM. Effect of rest interval length on repeated 1 repetition maximum back squats. J Strength Cond Res. 2003;17(4):634-7. [ Links ]

    20. Heyward VH. Advanced fitness assessment and exercise prescription. 6th ed. Champaign: Human Kinetics; 2010. Chapter 10, Assessing flexibility; p. 265-82. [ Links ]

    21. SAS Institute. SAS/STAT® user's guide, Version 9. Cary: SAS Institute; 2003. [ Links ]

    22. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG. 2006;113(10):1203-9. [ Links ]

    23. Premoli AC, Santana LF, Ferriani RA, Moura MD, Sá MFS, Reis RM. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2005;83(6):1852-5. [ Links ]

    24. Hakkinen K, Pakarinen A, Kraemer WJ, Hakkinen A, Valkeinen H, Alen M. Selective muscle hypertrophy, changes in EMG and force, and serum hormones during strength training in older women. J Appl Physiol. 2001;91(2):569-80. [ Links ]

    25. Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A. Enhanced mitogenic signaling in skeletal muscle in women with polycystic ovary syndrome. Diabetes. 2006;55(3):751-9. [ Links ]

    26. Soyupek F, Guney M, Eris S, Cerci S, Yildiz S, Mungan T. Evaluation of hand functions in women with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(10):571-5. [ Links ]

    27. Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, et al. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG. 2009;116(9):1242-50. [ Links ]

    28. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007;92(7):2500-5. [ Links ]

    29. Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008;23(1):153-9. [ Links ]

    30. Cosar E, Usok K, Akgun L, Koken G, Sahin FK, Arioz DT, et al. Body fat composition and distribution in women with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(8):428-32. [ Links ]

    31. Comerford KB, Almario RU, Kim K, Karakas SE. Lean mass and insulin resistance in women with polycystic ovary syndrome. Metabolism. 2012 Mar 17. [Epub ahead of print] [ Links ]

    32. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril. 2009;92(6):1966-82. [ Links ]